SMS Pharmaceuticals Ltd share price logo

SMS Pharmaceuticals Ltd Share Price

(SMSPHARMA)

₹211.477.25%

as on 02:29PM, 04 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Sms Pharma Performance

  • Day's Low

    Day's High

    ₹206.87
    Day's Price Range
    ₹228.99
  • 52 Week's Low

    52 Week's High

    ₹175.25
    52-Week Price Range
    ₹398
1 Month Return+ 19.5 %
3 Month Return-5.06 %
1 Year Return+ 15.51 %
Previous Close₹228.01
Open₹211.37
Volume1.61L
Upper Circuit₹273.61
Lower Circuit₹182.40
Market Cap₹1,930.15Cr

Sms Pharma Fundamentals

P/E Ratio

29.19

PEG Ratio

9.04

Market Cap

₹1,930.15 Cr

P/B Ratio

2.78

EPS

5.81

Dividend Yield

0.22

Sector

Pharmaceuticals

ROE

9.28

Key events for SMS Pharmaceuticals Ltd

  • SMS Pharma Completes USFDA Inspection Successfully - 22 Mar, 2025

    SMS Pharmaceuticals' Hyderabad facility successfully completed a USFDA inspection with one procedural observation. The company reported a 58.9% increase in Q3 FY25 net profit, reflecting strong operational performance.
  • SMS Pharma Reports Strong Q4 Results for December 2024 - 28 Feb, 2025

    SMS Pharmaceuticals reported a 7.35% increase in net sales to Rs 173.35 crore for December 2024, with net profit rising 58.9% to Rs 18.24 crore. EBITDA also grew by 15.91%. However, shares have declined 41.68% over the last six months.

Insights on SMS Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 32.26% to 32.47% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SMSPHARMA stock has moved up by 19.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 14.1 Cr → 18.24 Cr (in ₹), with an average increase of 22.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.3% return, outperforming this stock by 38.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 64.67% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.5% return, outperforming this stock by 6.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 198.05 Cr → 175.48 Cr (in ₹), with an average decrease of 11.4% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.52% to 0.31% in Dec 2024 quarter

Sms Pharma Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹161.48Cr (-)₹245.80Cr (↑52.22%)₹164.45Cr (↓33.10%)₹196.75Cr (↑19.64%)₹173.35Cr (↓11.89%)
Net Income₹12.29Cr (-)₹16.05Cr (↑30.59%)₹16.37Cr (↑1.99%)₹13.86Cr (↓15.33%)₹17.08Cr (↑23.23%)
Net Profit Margin7.61% (-)6.53% (↓14.19%)9.95% (↑52.37%)7.04% (↓29.25%)9.85% (↑39.91%)
Value in ₹ crore
Details2021202220232024
Total Assets₹835.28Cr (-)₹886.36Cr (↑6.12%)₹917.06Cr (↑3.46%)₹1,070.81Cr (↑16.77%)
Total Liabilities₹407.05Cr (-)₹392.59Cr (↓3.55%)₹421.96Cr (↑7.48%)₹500.31Cr (↑18.57%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹39.71Cr (-)₹90.45Cr (↑127.78%)₹45.06Cr (↓50.18%)₹22.45Cr (↓50.18%)₹50.12Cr (↑123.25%)

Sms Pharma Index Inclusions

BSE Healthcare

₹40,473.38

-3.34 (-1397.41%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹45,639.28

-3.91 (-1854.83%)

Sms Pharma Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
64.67%
0.00
Foreign Institutions
0.31%
-40.19
Mutual Funds
2.55%
0.01
Retail Investors
32.47%
0.64
Others
0%
400.00

Sms Pharma Key Indicators

Details20202021202220232024
Return On Assets %4.937.497.02-0.774.65
Details20202021202220232024
Book Value Per Share (₹)41.1448.555.5654.459.98
Details20202021202220232024
Earning Per Share (₹)3.867.28.020.465.81
Details20202021202220232024
Return On Equity %9.2415.3214.760.839.28

Sms Pharma Valuation

Sms Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-163.97x)

June 20, 2023

Today (29.19x)

April 3, 2025

Industry (52.58x)

April 3, 2025

Highest (2093.00x)

November 11, 2022

LowHigh

Sms Pharma Earnings and Dividends

  • SMS Pharmaceuticals Ltd Earnings Results

    SMS Pharmaceuticals Ltd’s net profit jumped 58.89% since last year same period to ₹18.24Cr in the Q3 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 29.36% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • SMS Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.18%.

    Read More about Dividends

Sms Pharma Technicals Summary

Bearish

Neutral

Bullish

Bearish

SMS Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.

Sms Pharma Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,930.15 Cr127.58%0.67₹49 Cr₹709 Cr
NA₹295.76 Cr27.56%0.55₹5 Cr₹44 Cr
BUY₹18,618.87 Cr-0.91%0.52NANA
NA₹2,128.80 Cr30.03%0.51₹58 Cr₹630 Cr
BUY₹24,606.34 Cr114.33%0.56₹552 Cr₹3,484 Cr

About Sms Pharma

SMS Pharmaceuticals Limited is a public company founded in December 1987. Focused on manufacturing Active Pharmaceutical Ingredients and intermediates, the company has two facilities in Hyderabad and one in Vijayanagaram Dist. During 2015, the company successfully completed US FDA audits, filed nine Drug Master Files, and became an associate company of M/s. VKT Pharma Private Limited by acquiring 1,225,900 equity shares. During 2016-17, the company also acquired 511,400 shares in Sireen Drugs Private Limited and invested in SMS Lifesciences India Limited. 2017-18 saw the Scheme of Arrangement between Demerged and Resulting Companies, approved by Hon’ble National Company Law Tribunal and investment of 784,100 equity shares in VKT Pharma PVT LTD. In FY 2018-19, the company had 38,501,65 equity shares in VKT Pharma PVT LTD.

Revenue: ₹173.35Cr as on December 2024 (Q4 24)
Net Profit: ₹17.08Cr as on December 2024 (Q4 24)
Listing date: 28 Feb, 2007
Chairperson Name: P Ramesh Babu
OrganisationSms Pharma
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on SMS Pharmaceuticals Ltd

What is SMS Pharmaceuticals Ltd price today?

SMS Pharmaceuticals Ltd share price today stands at ₹211.47, Open: ₹211.37, Previous Close: ₹228.01, High: ₹228.99, Low: ₹206.87, 52 Week High: ₹398, 52 Week Low: ₹175.25.

How to Buy SMS Pharmaceuticals Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy SMS Pharmaceuticals Ltd shares

What are today's traded volumes of SMS Pharmaceuticals Ltd?

Today's traded volume of SMS Pharmaceuticals Ltd(SMSPHARMA) is 1.61L.

What is today's market capitalisation of SMS Pharmaceuticals Ltd?

Today's market capitalisation of SMS Pharmaceuticals Ltd(SMSPHARMA) is ₹1930.15Cr.

What is the 52 Week High and Low Range of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd (SMSPHARMA)
Price
52 Week High
₹398
52 Week Low
₹175.25

How much percentage SMS Pharmaceuticals Ltd is down from its 52 Week High?

SMS Pharmaceuticals Ltd (SMSPHARMA) share price is ₹211.47. It is down -46.87% from its 52 Week High price of ₹398

How much percentage SMS Pharmaceuticals Ltd is up from its 52 Week low?

SMS Pharmaceuticals Ltd (SMSPHARMA) share price is ₹211.47. It is up 20.67% from its 52 Week Low price of ₹175.25